Johnson & Johnson on Thursday asked U.S. regulators to approve its single-dose COVID-19 vaccine for emergency use.
The vaccine, if approved, would be an efficient weapon in the fight against the coronavirus. States are putting messenger-RNA shots from Pfizer/BioNTech and Moderna into arms, but they must arrange to give a ...
from The Washington Times stories: Health https://ift.tt/3rmoZyD